Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1418 of 6351
-
New adaptive radiation trial aims to cut prostate cancer treatment time without sacrificing quality of life
Disease control Recruiting nowIn this prospective, multi-center cohort study, the tolerability and quality of life during ultrahypofractionated radiotherapy (RT) of early stage prostate cancer is surveyed at several institutions in Germany. Radiotherapy is delivered by an online-adaptive RT device (Varian Eth…
Sponsor: Jena University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a new pill slow Alzheimer's? early trial begins
Disease control Recruiting nowThis early phase, open label, single arm clinical trial will determine the intraindividual safety, tolerability and effects of NPC1 (parthenolide and ipriflavone) on blood-based biomarkers of Alzheimer's disease (AD) pathology among adults with subjective cognitive decline, mild …
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New hope for diabetic foot ulcers: can FoundationDRS solo speed up healing?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if using FoundationDRS Solo improves healing of chronic, non-healing foot ulcers in diabetic patients. The main question that this study aims to answer is: Does FoundationDRS Solo, when used in conjunction with standard of care wound …
Sponsor: Samaritan Biologics • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New pill targets Hard-to-Treat cancers with specific gene flaw
Disease control Recruiting nowAn international, multicenter, open-label, Phase 1/2 clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics, and efficacy of GenSci145, as monotherapy or in combination therapy, in participants with PIK3CA-mutated, locally advanced or metastatic soli…
Phase 1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Freezing, not cutting: new study tests cryoablation for breast cancer in seniors
Disease control Not yet recruitingThis study looks at a new way to treat early-stage breast cancer in older adults using a freezing technique called cryoablation. Older adults with early-stage breast cancer are usually treated with surgery or primary endocrine therapy (hormone therapy). While these treatments ca…
Sponsor: St. Antonius Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New pill could ease painful skin condition for those failed by antibiotics
Disease control Not yet recruitingThis is a Phase II clinical study to evaluate the safety, efficacy, pharmacokinetics and pharmacodynamics of QLS12010 capsules in the treatment of moderate to severe Hidradenitis Suppurativa (HS). The study is comprised of two parts: Part A is a multi-center, open-label, single-d…
Phase 2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Can a cool roof save lives? mexico trial aims to find out
Disease control Not yet recruitingAmbient air temperatures in Mexico have broken record highs in 2024. Solutions are needed to build heat resilience in communities and adapt to increasing heat from climate change. Sunlight-reflecting cool roof coatings may passively reduce indoor temperatures and energy use to pr…
Sponsor: Aditi Bunker • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Smart alerts aim to cut heart failure hospital stays
Disease control Not yet recruitingThe goal of this trial is to determine if the addition of the Heart Logic diagnostic alerts to standard of care therapies will lessen hospitalizations and improve quality of life in patients with heart failure.
Sponsor: Robert Pickett • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug cocktail aims to stall breast cancer
Disease control Not yet recruitingObjective: To explore the curative effect and safty of Changchun Ruibin metronomic chemotherapy combined with endistat in the treatment of HR positive HER2 negative advanced breast carcinoma.
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New 'Woundsome' technique aims to save legs from amputation
Disease control Not yet recruitingChronic limb-threatening ischemia (CLTI) is the most severe form of peripheral artery disease and remains a major health problem. Although the angiosome concept was introduced to guide revascularization by restoring direct blood flow to the affected tissue, its usefulness is limi…
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New gout pill BR2251 enters Mid-Stage trial
Disease control Not yet recruitingThis study is a randomized, double-blind, non-befloxacin-controlled, multicenter, phase II clinical trial, evaluating the efficacy, safety, and pharmacokinetic characteristics of BR2251 tablets when administered multiple times in subjects with primary gout and hyperuricemia. Thi…
Phase 2 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug duo aims to shrink tough lung cancer in 33-patient trial
Disease control Not yet recruitingThis is an single-arm, multicenter phase II study to evaluate the safety and efficacy of Sacituzumab Tirumotecan (sac-TMT) plus anlotinib in previously treated extensive-stage small cell lung cancer (ES-SCLC). The study is expected to enroll up to 33 eligible patients.
Phase 2 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Exercise before and during chemotherapy may boost treatment success
Symptom relief Not yet recruitingThis clinical study evaluates whether a supervised, multimodal therapeutic exercise program started before chemotherapy and continued during treatment can improve treatment outcomes in patients aged 35 to 65 years with breast, lung, or colon cancer. The study hypothesis is that …
Sponsor: University of Vic - Central University of Catalonia • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
New hope for advanced cancer: ALK-N001 enters human trials
Disease control Not yet recruitingThis study is a multicenter, open-label, dose-escalation and cohort-expansion Phase Ib/II clinical trial conducted in patients with advanced solid tumors, aiming to evaluate the safety, pharmacokinetics and efficacy of ALK-N001 for injection as monotherapy in the treatment of adv…
Phase 1/2 • Sponsor: Zhejiang Anglikang Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Brain zaps may boost memory after stroke – new trial tests it
Symptom relief Recruiting nowTo clarify the clinical efficacy of high-frequency rTMS on patients with post-stroke cognitive impairment, fNIRS and EEG techniques were used to observe the changes in brain functional activities of patients with post-stroke cognitive impairment after rTMS treatment, and to clari…
Sponsor: Qilu Hospital of Shandong University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Immune cells injected into brain to fight tumors
Disease control Recruiting nowThis is a multi-center, open-label investigator-initiated trial (IIT) designed to evaluate the safety, tolerability, and feasibility of combined intracranial and intravenous administration of ex vivo expanded and activated natural killer (NK) cells in adult patients with malignan…
Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New hope for aplastic anemia: drug combo aims to cut transfusions
Disease control Not yet recruitingThis study aimed to compare the efficacy and safety of enarodustat combined with cyclosporine versus cyclosporine monotherapy in the treatment of newly-diagnosed tansfusion-dependent non-severe aplastic anemia (TD-NSAA).
Phase 3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Peer power: young moms lead HIV prevention in zimbabwe
Prevention Not yet recruitingThis is a pilot cluster-randomized control trial co-led by Dr. Valentina Cambiano, Associate Professor of Epidemiology at University College London, UK and Professor Euphemia Sibanda, Research Director at the Centre for Sexual Health and HIV Research (CeSHHAR Zimbabwe). The goal …
Sponsor: University College, London • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Can mindfulness training ease student anxiety and depression?
Symptom relief CompletedThis study examines whether a four-week mindfulness-based intervention can reduce depression, anxiety, and stress among college students in Guangzhou, China. It also investigates whether changes in mindfulness, emotion regulation, and psychological resilience may help explain the…
Sponsor: Universiti Sains Malaysia • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Can a CT scan predict the future of gastric cancer?
Knowledge-focused Recruiting nowThe goal of this prospective observational study is to evaluate how well a previously developed prediction model can estimate outcomes in adults with gastric cancer. The model combines information from computed tomography (CT) images obtained before treatment with routine clinica…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC